Skip to content

Our Results

POC 1. Pilot trial in IBD: mean number of recruited patients/month

  • Data collected at Beaujon Hospital – Clichy, France
  • 12 trials (phase II, III and IV)
  • 42 months recruitment period : 21 before vs 21 with CT-SCOUT™
  • With CT-SCOUT™, the randomization rate is increased by 3 folds at both ICF signature and randomization

a ≠ b: p=0.01*
c ≠ d: p=0.02*

(*) Wilcoxon signed-rank test

Bouhnik Y et al. European Crohn’s Colitis Organisation (ECCO Congress)

Barcelona, Feb 2017

Download the chart

POC 2. Patient recruitment in two Phase 3 IBD (CD and UC) industrial clinical trials depending on CT-SCOUTTM equipment in 25 french sites

CT-SCOUT™ Premium sites randomization increased by 2 folds as compared to Freemium sites

CT-SCOUT™ Premium sites randomization increased by 4.5 folds as compared to non-equipped sites

Legend - POC 2

n>220 patients

Premium : Full Access to CT-SCOUT™ functionalities, including criteria review and SMS/email notifications

Freemium : Limited functions

*p < 0.05 with One-way ANOVA with post-hoc Tukey test

Download the chart

POC 3. Comparison of patient recruitment in two Phase 3 IBD clinical trials depending on access to CT-SCOUTTM recruitment platform

Multicenter prospective comparative study 134 sites and 644 patients

Results POC 3

Results POC 3

CT-SCOUT™ sites randomization increased by 2.8 folds as compared to other sites.

One-way ANOVA  (p < 0,05)  with post-hoc Tukey test

Download the chart

Testimony